P-102Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at a dose of 130mg/m2 (nacG-SOX130) in clinical(c)Stage III gastric cancer. (2nd July 2019) - Konishi, S; Manaka, D; Ikeda, Y; Ota, T; Kudo, R; Ann, H; Kawaguchi, K; Sasaki, N; Hamasu, S; Nishitai, R